San Diego, CA, United States of America

Jordan Neysmith

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Element Biosciences, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jordan Neysmith. Retrieved from https://idiyas.com/inventor/jordan-neysmith-gfcjedpw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jordan Neysmith: Innovator in Nucleic Acid Sequencing

Introduction

Jordan Neysmith is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid sequencing. His innovative work has led to the development of advanced technologies that enhance the efficiency and accuracy of genetic analysis.

Latest Patents

Jordan Neysmith holds a patent for "Flow Cell Devices and Optical Systems for Nucleic Acid Sequencing." This patent represents a crucial advancement in the tools available for genetic research and diagnostics. With 1 patent to his name, Neysmith's work is paving the way for future innovations in the field.

Career Highlights

Currently, Jordan Neysmith is employed at Element Biosciences, Inc., where he continues to push the boundaries of genetic technology. His role at the company allows him to collaborate with other talented professionals in the industry, contributing to groundbreaking advancements.

Collaborations

Some of his notable coworkers include Steve Xiangling Chen and Omid Khandan. Together, they work on various projects that aim to improve the capabilities of nucleic acid sequencing technologies.

Conclusion

Jordan Neysmith is a key figure in the biotechnology sector, with a focus on enhancing nucleic acid sequencing through innovative technologies. His contributions are vital to the ongoing evolution of genetic research and diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…